Click here to see how Octant is applying RIPTIDE to high throughput rational drug design.
“ We needed a robust, scalable, and low touch method for verifying full plasmid sequences…ideally, one that would not require a huge investment in labor and capital. We found RIPTIDE!”
- Sri Kosuri, Founder and CEO of Octant
|<$10 per sample|
|½ reaction volumes optional|
|Validated analysis pipeline.|
Ready to find out more?
Get in touch now.